Instil Bio Stock Analysis

Instil Stock Analysis Notes

About 68.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.42. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Instil Bio recorded a loss per share of 11.35. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 8th of December 2023. Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas. Instil Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 463 people. To find out more about Instil Bio contact Bronson Crouch at 972 499 3350 or learn more at https://instilbio.com.

Instil Bio Investment Alerts

Instil Largest EPS Surprises

View All Earnings Estimates

Instil Bio Environmental, Social, and Governance (ESG) Scores

Instil Stock Institutional Investors

Note, although Instil Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Instil Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 50.59 M.

Instil Profitablity

Management Efficiency

Instil Bio has Return on Asset of (0.1491) % which means that on every $100 spent on assets, it lost $0.1491. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.506) %, meaning that it generated no profit with money invested by stockholders. Instil Bio's management efficiency ratios could be used to measure how well Instil Bio manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.27. The value of Return On Capital Employed is expected to slide to -0.27. At this time, Instil Bio's Total Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 670.4 M this year, although the value of Other Current Assets will most likely fall to about 8.2 M.

Technical Drivers

As of the 7th of February, Instil Bio retains the Standard Deviation of 7.06, risk adjusted performance of (0.08), and Market Risk Adjusted Performance of (1.22). Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Instil Bio, as well as the relationship between them. Please check out Instil Bio market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Instil Bio is priced fairly, providing market reflects its last-minute price of 7.76 per share. Given that Instil Bio has information ratio of (0.13), we strongly advise you to confirm Instil Bio's regular market performance to make sure the company can sustain itself at a future point.

Instil Bio Price Movement Analysis

Instil Bio Insider Trading Activities

Instil Bio Outstanding Bonds

Instil Bio Predictive Daily Indicators

Instil Bio Corporate Filings

Instil Bio Forecast Models

Instil Bio's time-series forecasting models are one of many Instil Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Instil Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Instil Bio Bond Ratings

Instil Bio financial ratings play a critical role in determining how much Instil Bio have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Instil Bio's borrowing costs.

Instil Bio Debt to Cash Allocation

Instil Bio has 86.89 M in debt with debt to equity (D/E) ratio of 0.12, which may show that the company is not taking advantage of profits from borrowing. Instil Bio has a current ratio of 8.34, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Instil to invest in growth at high rates of return.

Instil Bio Total Assets Over Time

Instil Bio Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Instil Bio uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Instil Bio Debt Ratio

20.0

It seems most of the Instil Bio's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Instil Bio's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Instil Bio, which in turn will lower the firm's financial flexibility.

Instil Bio Corporate Bonds Issued

Instil Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how Instil Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Instil shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Instil Bio. By using and applying Instil Stock analysis, traders can create a robust methodology for identifying Instil entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Instil analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Instil analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Instil Bio stock analysis indicators help investors evaluate how Instil Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Instil Bio shares will generate the highest return on investment. By understating and applying Instil Bio stock analysis, traders can identify Instil Bio position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Instil Bio's market price often diverges from its book value, the accounting figure shown on Instil's balance sheet. Smart investors calculate Instil Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Instil Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.

Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.